P09.31 the Prognostic Value of Systemic Inflammatory Indices in Recurrent Glioma Treated With Bevacizumab

Neuro-Oncology - United Kingdom
doi 10.1093/neuonc/nox036.287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Prognostic Value of the S100B Protein in Newly Diagnosed and Recurrent Glioma Patients: A Serial Analysis

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2016English

Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2015English

Prognostic Significance of Inflammatory Indices in Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2020English

The Prognostic Value of the Systemic Inflammatory Response in Randomised Clinical Trials in Cancer: A Systematic Review

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2018English

Single-Institution Retrospective Review of Patients With Recurrent Glioblastoma Treated With Bevacizumab in Clinical Practice

Health Science Reports
2019English

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients With High-Grade Glioma

Academic Radiology
Nuclear MedicineRadiologyImaging
2016English

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients With Cervical Cancer

Scientific Reports
Multidisciplinary
2019English

Value of the Prognostic Nutritional Index in Advanced Gastric Cancer Treated With Preoperative Chemotherapy

Journal of Surgical Research
Surgery
2017English

Quantification of Edema Reduction Using Differential Quantitative T2 (DQT2) Relaxometry Mapping in Recurrent Glioblastoma Treated With Bevacizumab

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy